Biology Reference
In-Depth Information
4. Barouch DH, Kunstman J, Glowczwskie J,
et al
. (2003) Viral escape
from dominant simian immunodeficiency virus epitope-specific cyto-
toxic T lymphocytes in DNA-vaccinated rhesus monkeys.
J Virol
77
:
7367-7375.
5. Barouch DH, Kunstman J, Kuroda MJ,
et al
. (2002) Eventual AIDS
vaccine failure in a rhesus monkey by viral escape from cytotoxic T
lymphocytes.
Nature
415
: 335-339.
6. Barouch DH, Letvin NL. (2002) Viral evolution and challenges in the
development of HIV vaccines.
Vaccine
20
: A66-68.
7. Vogel TU, Reynolds MR, Fuller DH,
et al
. (2003) Multispecific vac-
cine-induced mucosal cytotoxic T lymphocytes reduce acute-phase
viral replication but fail in long-term control of simian immunodefi-
ciency virus SIVmac239.
J Virol
77
: 13348-13360.
8. Mascola JR, Lewis MG, VanCott TC,
et al
. (2003) Defining the pro-
tective antibody response for HIV-1 cellular immunity elicited by
human immunodeficiency virus type 1/ simian immunodeficiency virus
DNA vaccination does not augment the sterile protection afforded by
passive infusion of neutralizing antibodies.
Curr Mol Med
3
: 209-216.
9. Hilleman MR. (2001) Overview of the pathogenesis, prophylaxis and
therapeusis of viral hepatitis B, with focus on reduction to practical
applications.
Vaccine
19
: 1837-1848.
10. Robbins JB, Schneerson R, Szu SC. (1995) Perspective: hypothesis:
serum IgG antibody is sufficient to confer protection against infectious
diseases by inactivating the inoculum.
J Infect Dis
171
: 1387-1398.
11. Keller MA, Stiehm ER. (2000) Passive immunity in prevention and
treatment of infectious diseases.
Clin Microbiol Rev
13
: 602-614.
12. Klasse PJ, Sattentau QJ. (2001) Mechanisms of virus neutralization by
antibody.
Curr Top Microbiol Immunol
260
: 87-108.
13. Yang X, Kurteva S, Ren X,
et al
. (2005) Stoichiometry of envelope gly-
coprotein trimers in the entry of human immunodeficiency virus type 1.
J Virol
79
: 12132-12147.
14. Binley JM, Cayanan CS, Wiley C,
et al
. (2003) Redox-triggered infec-
tion by disulfide-shackled human immunodeficiency virus type 1
pseudovirions.
J Virol
77
: 5678-5684.
15. Chan DC, Kim PS. (1998) HIV entry and its inhibition.
Cell
93
:
681-684.
16. Golding H, Zaitseva M, de Rosny E,
et al
. (2002) Dissection of human
immunodeficiency virus type 1 entry with neutralizing antibodies to
gp41 fusion intermediates.
J Virol
76
: 6780-6790.
